Three members of uOttawa’s Faculty of Medicine have been named Canada Research Chairs, including one who has been renewed for a second term. These esteemed Faculty members are among five University of Ottawa researchers whose CRC appointments and renewals were announced on January 12 by the Honourable François-Philippe Champagne, minister of Innovation, Science and Industry.
The chair holders will expand the University of Ottawa’s breadth and depth of innovative research in areas such as neuroscience, neurobiology and cardiovascular disease. They will “build on our strengths to better understand and improve our world,” said Sylvain Charbonneau, vice-president, research and innovation.
Meet the Faculty of Medicine’s Canada Research Chairs:
The new Tier 2 Canada Research Chairs are:
Arezu Jahani-Asl (Faculty of Medicine), Canada Research Chair in Neurobiology of Disease
Professor Arezu Jahani-Asl studies neural stem cells, a group of cells that contribute to the plasticity and regeneration of the brain. At the same time, rewiring of these cells can lead to brain diseases, such as aggressive cancers and neurodevelopmental disorders. Professor Jahani-Asl is working on identifying molecular events and signalling pathways that are altered in these cells in the diseased brain, with the ultimate aim of finding better treatment for these diseases. Her research has also received funding for infrastructure from the Canada Foundation for Innovation’s John R. Evans Leaders Fund.
The renewed Tier 2 Canada Research Chair is held by:
Simon Chen (Faculty of Medicine), Canada Research Chair in Neural Circuits and Behaviour
An emerging leader in the field of in vivo imaging and neural dynamics, Professor Simon Chen aims to better understand the brain’s motor cortex, which is responsible for voluntary movement, and the neural circuit activity involved in motor skill learning. Uncovering such mechanisms will help shed light on post-traumatic recovery in motor-related brain injury and on diseases such as stroke and Parkinson’s.